Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 19, 2021 17:00 ET | Source: Routemaster Capital Inc.

Routemaster Capital Announces Uplisting to NEO Exchange, Transition to Single Purpose Company and Other Corporate Updates

TORONTO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Routemaster Capital Inc. (the “Company” or “Routemaster”) (TSXV: RM, GR: RMJR) is pleased to announce that it will be listing its common shares on the NEO...
January 18, 2021 08:00 ET | Source: RevoluGROUP Canada Inc.

RevoluGROUP Canada Inc. Launches RevoluPOS on Apple and Android

VANCOUVER, British Columbia, Jan. 18, 2021 (GLOBE NEWSWIRE) -- RevoluGROUP Canada Inc. (TSX-V: REVO), (Frankfurt: IJA2) (the "Company") is pleased to announce that it has officially launched the...
January 14, 2021 07:00 ET | Source: Routemaster Capital Inc.

Routemaster Capital Enters Into Definitive Agreement to Acquire Remaining 51% Interest in DeFi Holdings Inc., a Company Pursuing Investments in the Decentralized Finance Market

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Routemaster Capital Inc. (the “Company” or...
January 12, 2021 07:00 ET | Source: Routemaster Capital Inc.

DeFi Holdings Bermuda (A Subsidiary of Routemaster, TSXV: RM, GR: RMJR) Announces Investment in Diversified Basket of DeFi Protocols

TORONTO, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Routemaster Capital Inc. (the “Company” or “Routemaster”) (TSXV: RM) is pleased to announce that its Bermuda trading division, DeFi Holdings (Bermuda)...
January 11, 2021 01:15 ET | Source: Basilea Pharmaceutica AG

Basilea gibt vorläufige Umsatzzahlen für 2020 bekannt und berichtet über Fortschritte im Portfolio

Signifikanter Fortschritt bei der Vermarktung von Cresemba und Zevtera führte in 2020 zu innerhalb der Prognose liegenden Umsatzbeiträgen von CHF 112 Mio. aus den beiden ProduktenFortschritte im...
January 11, 2021 01:15 ET | Source: Basilea Pharmaceutica AG

Basilea reports preliminary 2020 revenue and portfolio progress

Significant progress made in the commercialization of Cresemba and Zevtera with 2020 revenue contributions of CHF 112 million in line with guidanceAdvancement in the FIDES clinical program with...
January 08, 2021 07:00 ET | Source: Routemaster Capital Inc.

DeFi Holdings (a Subsidiary of Routemaster, TSXV:RM, GR: RMJR) Announces Establishment of Investment and Trading Subsidiary in Bermuda and Partnership With Neversink River Capital

TORONTO, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Routemaster Capital Inc. (the “Company” or “Routemaster”) (TSXV: RM, GR: RMJR) is pleased to announce it has set up an investment and trading subsidiary in...
January 07, 2021 08:00 ET | Source: RevoluGROUP Canada Inc.

RevoluGROUP Canada Inc. To Issue 1 Million Stock Options

VANCOUVER, British Columbia, Jan. 07, 2021 (GLOBE NEWSWIRE) -- RevoluGROUP Canada Inc. (TSX-V: REVO), (Frankfurt: IJA2) (the "Company") is pleased to announce that incentive share options to...
January 07, 2021 01:15 ET | Source: Basilea Pharmaceutica AG

Basileas Partner Asahi Kasei Pharma schliesst Patientenrekrutierung in Phase-3-Studie mit Antimykotikum Isavuconazol (Cresemba®) in Japan ab

Basel, 07. Januar 2021 Basilea Pharmaceutica AG (SIX: BSLN) gab heute bekannt, dass die Patientenrekrutierung in der Phase-3-Studie mit dem Antimykotikum Isavuconazol (Cresemba®), die in Japan von...
January 07, 2021 01:15 ET | Source: Basilea Pharmaceutica AG

Basilea’s partner Asahi Kasei Pharma completes patient enrolment in phase 3 study with antifungal isavuconazole (Cresemba®) in Japan

Basel, Switzerland, January 07, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that patient enrolment has been completed in the phase 3 study with the antifungal isavuconazole...